|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 91.55 HKD | +6.08% |
|
+2.58% | +20.13% |
| Capitalization | 130B 150B 19.12B 16.2B 14.92B 14.09B 26.31B 1,780B 26.78B 176B 68.68B 855B 71.74B 70.22B 3,036B | P/E ratio 2025 |
146x | P/E ratio 2026 * | 52.4x |
|---|---|---|---|---|---|
| Enterprise value | 120B 137B 17.55B 14.87B 13.7B 12.93B 24.15B 1,634B 24.59B 161B 63.05B 785B 65.86B 64.47B 2,787B | EV / Sales 2025 |
8x | EV / Sales 2026 * | 6.42x |
| Free-Float |
93.21% | Yield 2025 * |
-
| Yield 2026 * | - |
Last Transcript: Innovent Biologics, Inc.
| 1 day | +6.14% | ||
| 1 week | +2.58% | ||
| Current month | +7.89% | ||
| 1 month | +8.92% | ||
| 3 months | +2.92% | ||
| 6 months | +7.01% | ||
| Current year | +20.13% |
| 1 week | 84.85 |  | 91.95 |
| 1 month | 75.9 | | 93.1 |
| Current year | 75.9 | | 93.8 |
| 1 year | 45.3 | | 109.1 |
| 3 years | 27.3 | | 109.1 |
| 5 years | 18.06 | | 109.1 |
| 10 years | 14 | | 109.1 |
| Manager | Title | Age | Since |
|---|---|---|---|
De Chao Yu
CEO | Chief Executive Officer | 62 | 2011-04-27 |
Fei You
DFI | Director of Finance/CFO | 47 | 2024-02-04 |
Ghang Shou Gao
CTO | Chief Tech/Sci/R&D Officer | - | 2020-10-31 |
| Director | Title | Age | Since |
|---|---|---|---|
De Chao Yu
CHM | Chairman | 62 | 2011-04-27 |
Charles Cooney
BRD | Director/Board Member | 81 | 2015-10-17 |
Hao Xi Ede
BRD | Director/Board Member | 67 | 2018-06-03 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +6.08% | +2.58% | +89.45% | +123.69% | 19.12B | |
| +1.21% | -0.63% | +32.30% | -8.90% | 77.53B | |
| +0.67% | +1.83% | +91.37% | +210.59% | 60.78B | |
| -0.90% | +53.60% | +53.60% | +53.60% | 48.37B | |
| +0.98% | -1.93% | -42.88% | -53.81% | 47.28B | |
| +1.47% | +1.91% | +50.06% | -37.89% | 26.26B | |
| +4.26% | +5.45% | +97.16% | -66.37% | 20.96B | |
| +2.24% | +4.27% | +64.96% | +31.13% | 19.44B | |
| +0.22% | +1.33% | +54.73% | +51.99% | 15.48B | |
| +0.08% | +8.34% | +123.62% | +428.70% | 15.11B | |
| Average | +1.65% | +1.23% | +61.44% | +73.27% | 35.03B | |
| Weighted average by Cap. | +1.25% | +0.38% | +50.41% | +57.16% |
| 2025 | 2026 * | |
|---|---|---|
| Net sales | 13.34B 15.33B 1.96B 1.66B 1.53B 1.44B 2.69B 182B 2.74B 17.97B 7.03B 87.53B 7.34B 7.19B 311B | 17.89B 20.57B 2.63B 2.23B 2.05B 1.93B 3.61B 244B 3.68B 24.1B 9.43B 117B 9.85B 9.64B 417B |
| Net income | 1.64B 1.89B 241M 204M 188M 177M 331M 22.42B 337M 2.21B 865M 10.77B 904M 885M 38.25B | 2.51B 2.89B 369M 312M 288M 272M 507M 34.32B 517M 3.38B 1.32B 16.49B 1.38B 1.35B 58.55B |
| Net Debt | -10.68B -12.27B -1.57B -1.33B -1.22B -1.15B -2.16B -146B -2.2B -14.38B -5.63B -70.08B -5.88B -5.76B -249B | -15.41B -17.71B -2.26B -1.92B -1.76B -1.67B -3.11B -210B -3.17B -20.75B -8.12B -101B -8.48B -8.3B -359B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-04-15 | 91.55 $ | +6.08% | 14,831,830 |
| 26-04-14 | 86.30 $ | -0.69% | 11,019,000 |
| 26-04-13 | 86.90 $ | -1.81% | 8,278,760 |
| 26-04-10 | 88.50 $ | +0.85% | 8,000,827 |
| 26-04-09 | 87.75 $ | -1.74% | 13,565,630 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- 1801 Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition